-
IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes.
J Immunol. 2007 Sep 15;179(6):3434-42
PMID: 17785777
-
Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site.
Immunity. 2001 Jul;15(1):35-46
PMID: 11485736
-
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens.
Nat Med. 2008 Mar;14(3):282-9
PMID: 18264109
-
Lambda interferon inhibits hepatitis B and C virus replication.
J Virol. 2005 Mar;79(6):3851-4
PMID: 15731279
-
Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.
Gastroenterology. 2006 Dec;131(6):1887-98
PMID: 17087946
-
An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity.
J Immunol. 2008 Feb 15;180(4):2474-85
PMID: 18250457
-
The IL-10R2 binding hot spot on IL-22 is located on the N-terminal helix and is dependent on N-linked glycosylation.
J Mol Biol. 2004 Sep 10;342(2):503-14
PMID: 15327950
-
Human interferon-lambda3 is a potent member of the type III interferon family.
Genes Immun. 2009 Mar;10(2):125-31
PMID: 18987645
-
Biological activity of interleukins-28 and -29: comparison with type I interferons.
Cytokine. 2005 Jul 21;31(2):109-18
PMID: 15899585
-
Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda1/IL-29).
Genes Immun. 2007 Jan;8(1):13-20
PMID: 17082759
-
IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.
Nat Immunol. 2003 Jan;4(1):69-77
PMID: 12483210
-
Interferons, interferon-like cytokines, and their receptors.
Immunol Rev. 2004 Dec;202:8-32
PMID: 15546383
-
Crystallography & NMR system: A new software suite for macromolecular structure determination.
Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21
PMID: 9757107
-
IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia.
Nat Med. 2008 Mar;14(3):275-81
PMID: 18264110
-
Role of deficient type III interferon-lambda production in asthma exacerbations.
Nat Med. 2006 Sep;12(9):1023-6
PMID: 16906156
-
Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases.
J Virol. 2007 Jul;81(14):7749-58
PMID: 17507495
-
Interleukin-10 and related cytokines and receptors.
Annu Rev Immunol. 2004;22:929-79
PMID: 15032600
-
Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response.
Genes Immun. 2007 Apr;8(3):254-61
PMID: 17361203
-
Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses.
PLoS Pathog. 2008 Sep 12;4(9):e1000151
PMID: 18787692
-
Maximum-likelihood density modification.
Acta Crystallogr D Biol Crystallogr. 2000 Aug;56(Pt 8):965-72
PMID: 10944333
-
Improved methods for building protein models in electron density maps and the location of errors in these models.
Acta Crystallogr A. 1991 Mar 1;47 ( Pt 2):110-9
PMID: 2025413
-
Viral infections activate types I and III interferon genes through a common mechanism.
J Biol Chem. 2007 Mar 9;282(10):7576-81
PMID: 17204473
-
Coot: model-building tools for molecular graphics.
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
PMID: 15572765
-
Structure of IL-22 bound to its high-affinity IL-22R1 chain.
Structure. 2008 Sep 10;16(9):1333-44
PMID: 18599299
-
[27] Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods.
Methods Enzymol. 1997;276:472-494
PMID: 27799110
-
PHENIX: building new software for automated crystallographic structure determination.
Acta Crystallogr D Biol Crystallogr. 2002 Nov;58(Pt 11):1948-54
PMID: 12393927
-
IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo.
PLoS Pathog. 2008 Mar 14;4(3):e1000017
PMID: 18369468
-
Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.
J Virol. 2006 May;80(9):4501-9
PMID: 16611910
-
IL-28, IL-29 and their class II cytokine receptor IL-28R.
Nat Immunol. 2003 Jan;4(1):63-8
PMID: 12469119
-
A short history of SHELX.
Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22
PMID: 18156677
-
IL-22R, IL-10R2, and IL-22BP binding sites are topologically juxtaposed on adjacent and overlapping surfaces of IL-22.
J Mol Biol. 2008 Oct 24;382(5):1168-83
PMID: 18675824
-
Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex.
J Biol Chem. 2006 Nov 17;281(46):35088-96
PMID: 16982608
-
Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes.
Hepatology. 2006 Oct;44(4):896-906
PMID: 17006906
-
Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells.
Blood. 2006 Jun 1;107(11):4417-23
PMID: 16478884
-
Crystal structure of the IL-22/IL-22R1 complex and its implications for the IL-22 signaling mechanism.
FEBS Lett. 2008 Sep 3;582(20):2985-92
PMID: 18675809